Dial Schedule M: India’s drug manufacturing practices to undergo major overhaul
If you are a pharmaceutical company in India with a turnover of more than Rs. 250 crores, you only... Read More
Payment Banks and Ways to Steer Clear from RBI’s Wrath – The Regulatory Regime
Reams have already been written on the RBI’s recent decision to impose stringent strictures on... Read More
NBFCs to implement technology-driven compliance solution by October 31st 2024: RBI
If you are a upper or middle layer[1] Non-Banking Financial Company (“NBFC”) or a part of other... Read More